Opioids research finds overdose risk factors
New research from the University of Stirling has identified potential major risk factors leading to overdose in patients taking prescription medication.
Jun 28, 2021
0
2
New research from the University of Stirling has identified potential major risk factors leading to overdose in patients taking prescription medication.
Jun 28, 2021
0
2
(HealthDay)—The first biosimilar to Lucentis (ranibizumab injection) has been approved for the treatment of neovascular (wet) age-related macular degeneration and other eye diseases and conditions, the U.S. Food and Drug ...
Sep 24, 2021
0
11
Department of Health and Human Services officials said Tuesday that the safety benefits of electronic health records far outweigh any potential problems, but critics say regulators are pushing health care providers to use ...
Feb 4, 2015
0
7
(HealthDay)—The 32-mg, single intravenous dose of Zofran (ondansetron), an anti-nausea drug, is being removed from the market due to its potential to cause serious, even fatal, cardiac damage, according to a Drug Safety ...
Dec 6, 2012
0
0
A team of scientists led by researchers at the University of Georgia Center for Food Safety in Griffin has developed a machine-learning approach that could lead to quicker identification of the animal source of certain Salmonella ...
Feb 11, 2019
0
3
Prescribing of strong opioid medications for non-cancer pain in the United States has nearly doubled over the past decade, reports a study in the October issue of Medical Care.
Sep 16, 2013
0
0
(Medical Xpress)—In the first study to examine discussion of drug side effects on Internet message boards, researchers from the Perelman School of Medicine at the University of Pennsylvania found that breast cancer survivors ...
Jan 16, 2013
0
0
When it comes to food safety in the kitchen, it's important to keep your work area clean from bacteria and the possibility of cross-contamination. It's best to use hot, soapy water to wash utensils, cutting boards and other ...
Sep 20, 2021
1
2
Orgovyx (relugolix) is now approved to treat advanced prostate cancer and is the first oral hormone therapy approved for this indication, the U.S. Food and Drug Administration announced Friday.
Dec 22, 2020
0
7
(AP) -- Federal health officials are adding new safety warnings about risks of memory loss and elevated blood sugar to statins, a widely prescribed group of cholesterol-lowering medications.
Feb 28, 2012
0
0